Clinical trials
Phase 2 COVID-19 trials in Argentina
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2020 | 9 |
| 2021 | 7 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 11 |
| Terminated | 4 |
| Not yet recruiting | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Asociación Argentina de Medicina Hiperbárica e Investigación | 1 |
| AstraZeneca | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
| BioAge Labs, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Fundación Huésped | 1 |
| GlaxoSmithKline | 1 |
| Golden Biotechnology Corporation | 1 |
| Hospital de Infecciosas Francisco Javier Muniz | 1 |
| Janssen Vaccines & Prevention B.V. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| COVID-19 | 17 |
| Severe Acute Respiratory Syndrome | 3 |
| Coronavirus Infections | 2 |
| Acute Lung Injury | 1 |
| Hypoxia | 1 |
| Lung Diseases, Interstitial | 1 |
| Pneumonia | 1 |
| Post-Acute COVID-19 Syndrome | 1 |
| Pulmonary Fibrosis | 1 |
| Respiratory Distress Syndrome | 1 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.